Our study using immunohistochemistry in AD and control brains, however, implied a somewhat more complex pathological pattern than A1 (C3 immunopositive) astrocytes having the main pathogenic role and A2 (S100A10 immunopositive) astrocytes being much less important. The gene discussed is S100A10; the disease is Alzheimer disease.